Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- QGEN +2.8% (guidance)
Other news:
- NMAX +6% (files for 121,288,655 share common stock offering by selling shareholders, relates to warrants)
- VTRS +3.3% (statement on nationwide settlement to resolve opioid-related claims)
- CVAC +3.1% (receives U.S. FDA IND clearance to initiate phase 1 clinical trial for novel mRNA-based precision immunotherapy in squamous non-small cell lung cancer)
- DK +2.2% (names Robert Wright as CFO of the Partnership)
- SMHI +1.5% (announces securities repurchase)
- VZLA +1.1% (temporarily pauses field work at the Panuco project due to current security conditions in the area)